![]() ![]() On the international front, we have also made substantial progress and are in process of expanding our direct footprint and bolstering our distribution relationships. We are driving pipeline process rigor and fully expect our team to drive solid order growth over the course of this year. team is fully in place and training is well under way. It's important to state that all of these efforts are underpinned by a clear understanding of what each of our key constituents is looking for us to deliver. Let's move on to share the progress we're making on the commercial, operational, clinical, and innovation fronts. For full-year 2018, we received new orders of approximately $141 million, an increase of almost 25% over prior year, and total revenue in 2018 was $81 million, an increase of 138% over prior year. Total revenue in the quarter was $20.7 million versus $19.9 million in the prior period. Q4 financial highlights include MRIdian System orders of approximately $49 million, an increase of 43% versus prior year. Our teammate and customer willingness to recommend scores indicate that we're on the right path. ![]() We have defined our mission, vision and shared values that will guide and ensure our success, and we have put operational rigor in place to drive our key strategic imperatives that we call are vital few and key drivers. In a short period of time, we have built a leadership team very capable of growing and scaling the company. As you know, Q4 was our new management team's first full quarter with the company and I would describe it as solid. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |